Event Date/Time: Apr 16, 2012 End Date/Time: Apr 17, 2012
Report as Spam


SMi present their 8th annual Asthma & COPD event to be held in London on Monday 16th & Tuesday 17th of April 2012. Building on the success of our previous Asthma & COPD, and COPD: Novel Therapeutics and Management Strategies events, this year will see an elite panel of speakers drawn for both industry and academia.
The successful combination of academic KOLs and leading senior big Pharma speakers offers an ideal and comprehensive platform for the study of both Asthma & COPD.
The similarities between the two conditions are juxtaposed with the subtle and important differences. Both pose unique and complex challenges, and these differences must be identified and isolated. As respiratory research continues to grow and prosper this event contributes further towards the understanding of how they can be dealt with in a successful and cost effective manner.
This event offers an ideal platform for those who have recently moved in to respiratory studies as well as established professionals. This is an opportunity to network with the leading protagonists in the field and to learn from their knowledge and experience as well as to share your own.

6 Key Reasons to attend:
Study comparisons of exacerbations of Asthma & COPD
Analyse the EXACT-PRO initiative and take lessons from it
Understand combination therapies; clinical and exercise therapies. How can these be used more and more effectively
Isolate unmet needs in Asthma & COPD and debate how these needs can be met and addressed
Expand your knowledge of biomarkers in Asthma & COPD - discovery and validation
Develop and analyse ideas for new end points required for regulatory outcomes


Additional Information

PLUS 2 HALF-DAY POST-CONFERENCE WORKSHOPS Workshop A: Opening up COPD drugs to market 18th April 2012, Copthorne Tara Hotel, London, 8.30am – 12.30pm Led by: Miles Houslay, CEO, BioGryffe Consulting Workshop B: Synergizing COPD drug development of big and small pharmaceutical companies 18th April 2012, Copthorne Tara Hotel, London, 1.30pm – 5.30pm Workshop Content Advisors: Mary Fitzgerald, Executive VP Respiratory, Pulmagen Daniel Bock, Director Pre-clinical & Clinical R&D, Revotar